PRICES include / exclude VAT
>BSI Standards >11 HEALTH CARE TECHNOLOGY>11.100 Laboratory medicine>11.100.20 Biological evaluation of medical devices>BS EN ISO 10993-7:2026 - TC Tracked Changes. Biological evaluation of medical devices Ethylene oxide sterilization residuals
immediate downloadReleased: 2026-05-26
BS EN ISO 10993-7:2026 - TC Tracked Changes. Biological evaluation of medical devices Ethylene oxide sterilization residuals

BS EN ISO 10993-7:2026 - TC

Tracked Changes. Biological evaluation of medical devices Ethylene oxide sterilization residuals

Format
Availability
Price and currency
English Secure PDF
Immediate download
Printable - You are authorized to print 1 copy
654.49 USD
English Hardcopy
In stock
654.49 USD
Standard number:BS EN ISO 10993-7:2026 - TC
Pages:360
Released:2026-05-26
ISBN:978 0 539 42404 1
Status:Tracked Changes
DESCRIPTION

BS EN ISO 10993-7:2026 - TC


This standard BS EN ISO 10993-7:2026 - TC Tracked Changes. Biological evaluation of medical devices is classified in these ICS categories:
  • 11.100.20 Biological evaluation of medical devices
This document specifies allowable limits (AL) for residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) in EO-sterilized medical devices, procedures for the measurement of EO and ECH, and methods for determining conformity so that devices can be released. Additional background, including guidance and a flowchart showing how this document is applied, are also included in Annexes A, B, C, D, E, F, G, H, I, J and K. EO-sterilized devices or components that have neither direct nor indirect body or user contact (e.g. in vitro diagnostic devices) are out of scope of this document. This document does not apply to devices that have been demonstrated to not absorb or retain EO or its degradation product ECH, such as medical devices made exclusively of metal alloys and glass, see Clause C.5[228]. NOTE            This document does not specify limits for ethylene glycol (EG). No device limits are specified for EG because the risk assessment in Annex F indicates that calculated allowable levels are higher than those likely to occur in a medical device.